Table 1

Clinicopathologic characteristics of 19 head and neck cancer patients evaluated prospectively for Stat3 activation/expression

Gender
 Male15  (79%)
 Female4  (21%)
AgeMean, 60.83 years; Median, 62.5 years; range, 38–76 years
Tumor Site
 Oral cavity8  (42%)
 Oropharynx4  (21%)
 Hypopharynx2  (10%)
 Larynx4  (21%)
 Unknown1  (5%)
T Stage
 1–212  (63%)
 3–47  (37%)
N Stage
 0–111  (58%)
 28  (42%)
Tumor differentiation
 Well1  (5%)
 Moderate16  (90%)
 Poor1  (5%)